Prakash Kotagal, MD

Appointed
1984

Education & Fellowships

Fellowship - Cleveland Clinic
Epilepsy Fellowship
Cleveland, OH United States
1988

Fellowship - Cleveland Clinic Epilepsy Training Program
Cleveland, OH
1988

Residency - Cleveland Clinic
Child Neurology
Cleveland, OH
1986

Residency - Saint Louis University School of Medicine
Pediatrics
St. Louis, MO
1983

Residency - St. Louis University Hospital
Pediatrics
St. Louis, MO
1982

Residency - All India Institute of Medical Sciences
Internal Medicine
New Delhi, India, IN
1981

Internship - Jawaharlal Nehru Institute
Puducherry, India, IN
1979

Medical Education - University of Madras, Jawaharlal Institute, Pondicherry
MD
Pondicherry, In
1978

Medical Education - Jawaharlal Nehru Institute, Pondicherry, India (University of Madras)
Puducherry, India, IN

Certifications

• Pediatrics
• Neurology - Neurology with Special Qualifications in Child Neurology
• Neurology - Epilepsy

Specialty Interests

children with complex epilepsies, children with epilepsy and Sturge Weber Syndrome, children with first seizure, clinical drug trials, diagnostic video EEG for pediatric seizure disorders, EEG, Epilepsy, epilepsy and epilepsy surgery in children and adolescents, Epilepsy surgery and medical treatment of epilepsy in children, invasive EEG monitoring for pre-surgical evaluations, Pediatric Epilepsy, pediatric epilepsy and epilepsy surgery, Rasmussen's encephalitis and medically refractory status epilepticus., Seizure disorder treatment and surgery in brain malformations, seizure manifestations, Sturge Weber syndrome, the relationship between sleep and epilepsy, Tuberous Sclerosis Complex, vagus nerve stimulation, Video EEG, pediatric sleep disorders

Awards & Honors

• 1989 Peskind Award, Cleveland Clinic for best scientific paper
• 2008 Honoree Epilepsy Association of Northeast Ohio

See publications for Prakash Kotagal, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/26/2024, Dr. Kotagal has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.